Avalyn’s Phase 1a trial of AP02 assessed clinical tolerability and pharmacokinetic profiles in three SAD cohorts, up to a maximum 2.0 mg dose in HVs; two BAL cohorts in HVs; and one cohort of patients ...

The LUNG FORCE Walk is a celebratory and welcoming event that provides critical funds for lifesaving lung cancer research, early detection initiatives and awareness on outreach to vulnerable ...

Dana-Farber Cancer Institute investigators launch a first-of-its kind study to use a novel blood test to identify people who ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral presentation, at the 2025 ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Manmeet Ahluwalia, MD, MBA, FASCO, discussed the significance of National Cancer Research Month and highlighted how ongoing ...

Let's celebrate the unsung heroes of the corporate world! On International HR Day 2025, we shine a spotlight on the tireless ...

A forgotten fitness pioneer built an empire on the idea of creating a space for everyday women. Her devotees are still ...

Many things can get in the way of taking care of ourselves ... which helps your heart, lungs, and muscles. One frequently cited study has even linked humor and laughter to improved immune function ...

Yet, while Medicare-insured blood cancer survivors suffered worse financial strain, difficulty in affording care and taking fewer medications as a result was present across all survivors studied.

ASCO Annual Meeting Zymeworks and its partners will present multiple abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 ? June 4, 2025 in Chicago, IL.